Skip to content

Determine the Clinical Advantage of IV vs PO Acetaminophen

Comparative Efficacy of Intravenous Acetaminophen vs. Oral Acetaminophen in Ambulatory Surgery

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03558555
Enrollment
103
Registered
2018-06-15
Start date
2017-12-08
Completion date
2018-12-30
Last updated
2020-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal Hernia

Keywords

Acetaminophen, Tylenol, Intravenous versus oral

Brief summary

There is limited research on the clinical outcome differences between intravenous (IV) acetaminophen versus oral (PO) acetaminophen. With the costs of intravenous acetaminophen sometimes being almost 100 times the cost of PO acetaminophen, it is not only important fiscally but also clinically to differentiate the benefits of IV vs PO acetaminophen. The proposed research study is to determine the clinical advantages of IV vs PO acetaminophen during the post-operative recovery time for ambulatory surgery patients by analyzing differences in time to first opioid delivery, pain scores, and patient satisfaction.

Detailed description

In previous literature it has been shown that compared to placebo, IV acetaminophen can improve postoperative pain scores and reduce opioid requirements. In addition, IV acetaminophen has several pharmacokinetic properties that may be beneficial when compared to acetaminophen. IV acetaminophen has been shown to achieve a more rapid and higher maximum plasma concentration as well as higher cerebrospinal fluid concentrations. Comparative effectiveness trials of IV vs PO administration have not conclusively demonstrated improved clinical outcomes despite the proposed pharmacokinetic benefits. More research needs to be conducted to determine possible clinical advantages.

Interventions

DRUGAcetaminophen IV Soln

1000mg of IV acetaminophen

oral acetaminophen 975mg pills

DRUGPlacebo Pills

placebo match to acetaminophen

DRUGSaline

Intravenous saline

Sponsors

Yan Lai
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

Participants presenting for inguinal hernia surgery are assigned to either the oral or intravenous acetaminophen group

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* ASA scores I-III * Ambulatory surgery patients * Ages 18-75 * Surgeries requiring general anesthesia for hernia surgery

Exclusion criteria

* Patients with contraindications to acetaminophen (history of end organ liver dysfunction) * Known allergy to acetaminophen * Emergency surgery * Patients who were not fasted * Patients who cannot tolerate PO * Surgery anticipated to last longer than 3 hours or requiring re-dose of acetaminophen * Pregnancy * Weight less than 50kg * Chronic daily narcotic use * Patients who's anesthetic plan requires regional anesthesia * Patient refusal to participate or do not have capacity to provide consent.

Design outcomes

Primary

MeasureTime frameDescription
PACU Visual Analogue Pain Scoresbaseline, 1 hour, and Day 1 dischargePost-Anesthesia Care Unity (PACU) pain scores at baseline, 1 hour, and on discharge from PACU. Pain score by visual analogue score, total scale from 0 to 10 with 10 being the worse pain.
Total MME IntraoperativelyDay 1Total Morphine Milligram Equivalent (MME) use intraoperatively
Total Narcotic Use in PACU.Day 1Total narcotic use in PACU expressed in total morphine milligram equivalents (MME)

Secondary

MeasureTime frameDescription
PACU Length of Stayup to 24 hours after PACU arrivalTime in PACU
Patient Reported Total Narcotic Use Post-dischargeaverage 7 dayshome opiod use
Patient Satisfaction.7 days post surgeryPatient satisfaction total scale from 1 to 10, with higher score indicating more satisfaction

Countries

United States

Participant flow

Recruitment details

Participants presenting for laparoscopic hernia repair under general anesthesia in an ambulatory setting were recruited from July 2017 to December 2018. First enrollment in Dec 2017.

Participants by arm

ArmCount
Oral Acetaminophen
Oral acetaminophen 975mg preoperatively and receive intravenous saline intraoperatively.
56
Acetaminophen IV Soln
Acetaminophen 1000mg IV Soln after induction of general anesthesia and placebo pills preoperatively
44
Total100

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up21

Baseline characteristics

CharacteristicOral AcetaminophenAcetaminophen IV SolnTotal
Age, Continuous53.93 years
STANDARD_DEVIATION 13.37
52.52 years
STANDARD_DEVIATION 15.1
53.31 years
STANDARD_DEVIATION 14.1
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
23 Participants20 Participants43 Participants
Sex: Female, Male
Male
33 Participants24 Participants57 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 560 / 44
other
Total, other adverse events
0 / 560 / 44
serious
Total, serious adverse events
0 / 560 / 44

Outcome results

Primary

PACU Visual Analogue Pain Scores

Post-Anesthesia Care Unity (PACU) pain scores at baseline, 1 hour, and on discharge from PACU. Pain score by visual analogue score, total scale from 0 to 10 with 10 being the worse pain.

Time frame: baseline, 1 hour, and Day 1 discharge

ArmMeasureGroupValue (MEAN)Dispersion
Oral AcetaminophenPACU Visual Analogue Pain Scores1 hour2.88 score on a scaleStandard Deviation 2.74
Oral AcetaminophenPACU Visual Analogue Pain ScoresDischarge from PACU, up to 2.5 hours1.45 score on a scaleStandard Deviation 1.51
Oral AcetaminophenPACU Visual Analogue Pain Scores6 hour post op3.82 score on a scaleStandard Deviation 2.28
Oral AcetaminophenPACU Visual Analogue Pain Scores24 hour post op3.64 score on a scaleStandard Deviation 2.26
Oral AcetaminophenPACU Visual Analogue Pain ScoresBaseline2.13 score on a scaleStandard Deviation 2.72
Acetaminophen IV SolnPACU Visual Analogue Pain ScoresBaseline1.52 score on a scaleStandard Deviation 2.44
Acetaminophen IV SolnPACU Visual Analogue Pain Scores24 hour post op4.16 score on a scaleStandard Deviation 1.83
Acetaminophen IV SolnPACU Visual Analogue Pain ScoresDischarge from PACU, up to 2.5 hours1.59 score on a scaleStandard Deviation 1.44
Acetaminophen IV SolnPACU Visual Analogue Pain Scores1 hour2.41 score on a scaleStandard Deviation 2.21
Acetaminophen IV SolnPACU Visual Analogue Pain Scores6 hour post op4.27 score on a scaleStandard Deviation 1.74
Primary

Total MME Intraoperatively

Total Morphine Milligram Equivalent (MME) use intraoperatively

Time frame: Day 1

ArmMeasureValue (MEAN)Dispersion
Oral AcetaminophenTotal MME Intraoperatively63.75 MMEStandard Deviation 21.33
Acetaminophen IV SolnTotal MME Intraoperatively57.24 MMEStandard Deviation 29.2
Primary

Total Narcotic Use in PACU.

Total narcotic use in PACU expressed in total morphine milligram equivalents (MME)

Time frame: Day 1

ArmMeasureValue (MEAN)Dispersion
Oral AcetaminophenTotal Narcotic Use in PACU.11.33 MMEStandard Deviation 17.1
Acetaminophen IV SolnTotal Narcotic Use in PACU.9.83 MMEStandard Deviation 11.99
Secondary

PACU Length of Stay

Time in PACU

Time frame: up to 24 hours after PACU arrival

ArmMeasureValue (MEAN)Dispersion
Oral AcetaminophenPACU Length of Stay82.93 minutesStandard Deviation 55.79
Acetaminophen IV SolnPACU Length of Stay64.05 minutesStandard Deviation 33.13
Secondary

Patient Reported Total Narcotic Use Post-discharge

home opiod use

Time frame: average 7 days

ArmMeasureValue (MEAN)Dispersion
Oral AcetaminophenPatient Reported Total Narcotic Use Post-discharge14.06 MMEStandard Deviation 14.02
Acetaminophen IV SolnPatient Reported Total Narcotic Use Post-discharge17.56 MMEStandard Deviation 17.42
Secondary

Patient Satisfaction.

Patient satisfaction total scale from 1 to 10, with higher score indicating more satisfaction

Time frame: 7 days post surgery

Population: one missing survey

ArmMeasureValue (MEAN)Dispersion
Oral AcetaminophenPatient Satisfaction.5.05 score on a scaleStandard Deviation 2.18
Acetaminophen IV SolnPatient Satisfaction.6.20 score on a scaleStandard Deviation 3.01

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026